Immunicom
Issac Noorwala is a qualified Quality Assurance Specialist II at Immunicom, Inc. since November 2020, responsible for ensuring compliance with FDA regulations and maintaining a Quality Management System. Previously, Issac served as a Quality Assurance Analyst and Quality Assurance Intern, where contributions included implementing a new training system for the QMS. Prior experience includes IT Support Intern at Bright Horizon Academy, where Issac established a learning lab and configured network infrastructure, and a role at Lorem Cytori USA, Inc. focusing on quality assurance and regulatory affairs with responsibilities in revising SOPs and engaging in compliance audits. Early career roles include Wireless Consultant at T-Mobile, assisting customers with service upgrades, and Park Host at SeaWorld San Diego, enhancing visitor experiences. Issac holds a Bachelor of Science in Management Information Systems from San Diego State University and an Associate of Science in Business Administration from San Diego Mesa College.
Immunicom
Immunicom is developing a non-drug-based cancer therapy with the potential to reduce treatment side effects, enhance therapy response rates and improve cancer patients’ quality of life – all at significantly lower costs and without the side effects and complications prevalent in existing immunotherapy approaches. Immunicom's cancer therapy can allow the body’s natural immune system to directly attack cancer while enhancing the effects of other cancer treatments that may be used concurrently.